Angiopoietin 2 stimulates TIE2-expressing monocytes to suppress T cell activation and to promote regulatory T cell expansion
- PMID:21368233
- DOI: 10.4049/jimmunol.1002802
Angiopoietin 2 stimulates TIE2-expressing monocytes to suppress T cell activation and to promote regulatory T cell expansion
Abstract
Angiopoietin 2 (ANGPT2) is a proangiogenic cytokine whose expression is often upregulated by endothelial cells in tumors. Expression of its receptor, TIE2, defines a highly proangiogenic subpopulation of myeloid cells in circulation and tumors called TIE2-expressing monocytes/macrophages (TEMs). Genetic depletion of TEMs markedly reduces tumor angiogenesis in various tumor models, emphasizing their essential role in driving tumor progression. Previously, we demonstrated that ANGPT2 augments the expression of various proangiogenic genes, the potent immunosuppressive cytokine, IL-10, and a chemokine for regulatory T cells (Tregs), CCL17 by TEMs in vitro. We now show that TEMs also express higher levels of IL-10 than TIE2(-) macrophages in tumors and that ANGPT2-stimulated release of IL-10 by TEMs suppresses T cell proliferation, increases the ratio of CD4(+) T cells to CD8(+) T cells, and promotes the expansion of CD4(+)CD25(high)FOXP3(+) Tregs. Furthermore, syngeneic murine tumors expressing high levels of ANGPT2 contained not only high numbers of TEMs but also increased numbers of Tregs, whereas genetic depletion of tumor TEMs resulted in a marked reduction in the frequency of Tregs in tumors. Taken together, our data suggest that ANGPT2-stimulated TEMs represent a novel, potent immunosuppressive force in tumors.
Similar articles
- Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions.Coffelt SB, Tal AO, Scholz A, De Palma M, Patel S, Urbich C, Biswas SK, Murdoch C, Plate KH, Reiss Y, Lewis CE.Coffelt SB, et al.Cancer Res. 2010 Jul 1;70(13):5270-80. doi: 10.1158/0008-5472.CAN-10-0012. Epub 2010 Jun 8.Cancer Res. 2010.PMID:20530679
- TIE-2 and VEGFR kinase activities drive immunosuppressive function of TIE-2-expressing monocytes in human breast tumors.Ibberson M, Bron S, Guex N, Faes-van't Hull E, Ifticene-Treboux A, Henry L, Lehr HA, Delaloye JF, Coukos G, Xenarios I, Doucey MA.Ibberson M, et al.Clin Cancer Res. 2013 Jul 1;19(13):3439-49. doi: 10.1158/1078-0432.CCR-12-3181. Epub 2013 May 6.Clin Cancer Res. 2013.PMID:23649001
- The influence of excessive IL-6 production in vivo on the development and function of Foxp3+ regulatory T cells.Fujimoto M, Nakano M, Terabe F, Kawahata H, Ohkawara T, Han Y, Ripley B, Serada S, Nishikawa T, Kimura A, Nomura S, Kishimoto T, Naka T.Fujimoto M, et al.J Immunol. 2011 Jan 1;186(1):32-40. doi: 10.4049/jimmunol.0903314. Epub 2010 Nov 24.J Immunol. 2011.PMID:21106853
- Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2.Lewis CE, De Palma M, Naldini L.Lewis CE, et al.Cancer Res. 2007 Sep 15;67(18):8429-32. doi: 10.1158/0008-5472.CAN-07-1684.Cancer Res. 2007.PMID:17875679Review.
- The paracrine role of Tie-2-expressing monocytes in tumor angiogenesis.Ribatti D.Ribatti D.Stem Cells Dev. 2009 Jun;18(5):703-6. doi: 10.1089/scd.2008.0385.Stem Cells Dev. 2009.PMID:19186995Review.
Cited by
- T-regulatory cells: key players in tumor immune escape and angiogenesis.Facciabene A, Motz GT, Coukos G.Facciabene A, et al.Cancer Res. 2012 May 1;72(9):2162-71. doi: 10.1158/0008-5472.CAN-11-3687.Cancer Res. 2012.PMID:22549946Free PMC article.Review.
- Ang-2 promotes lung cancer metastasis by increasing epithelial-mesenchymal transition.Dong Z, Chen J, Yang X, Zheng W, Wang L, Fang M, Wu M, Yao M, Yao D.Dong Z, et al.Oncotarget. 2018 Jan 9;9(16):12705-12717. doi: 10.18632/oncotarget.24061. eCollection 2018 Feb 27.Oncotarget. 2018.PMID:29560103Free PMC article.
- Targeting angiogenesis in oncology, ophthalmology and beyond.Cao Y, Langer R, Ferrara N.Cao Y, et al.Nat Rev Drug Discov. 2023 Jun;22(6):476-495. doi: 10.1038/s41573-023-00671-z. Epub 2023 Apr 11.Nat Rev Drug Discov. 2023.PMID:37041221Review.
- Targeting tumor-associated macrophages to reverse antitumor drug resistance.Li S, Sheng J, Zhang D, Qin H.Li S, et al.Aging (Albany NY). 2024 May 23;16(11):10165-10196. doi: 10.18632/aging.205858. Epub 2024 May 23.Aging (Albany NY). 2024.PMID:38787372Free PMC article.Review.
- Suppression of KSHV-induced angiopoietin-2 inhibits angiogenesis, infiltration of inflammatory cells, and tumor growth.Yu X, Sha J, Xiang S, Qin S, Conrad P, Ghosh SK, Weinberg A, Ye F.Yu X, et al.Cell Cycle. 2016 Aug 2;15(15):2053-65. doi: 10.1080/15384101.2016.1196303. Epub 2016 Jun 13.Cell Cycle. 2016.PMID:27294705Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous